Skip to content
2000
Volume 25, Issue 13
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Introduction

Hypophysitis is a rare inflammatory disorder of the pituitary gland. Symptoms and signs of hypophysitis can be various, progressing insidiously, and its recognition may be challenging.

Case Presentation

We report the clinical history and therapeutic management of a 59-year-old man diagnosed with arginine vasopressin deficiency (AVP-D) due to an infundibulo-neuro-hypophysitis (INH) that occurred after the patient had inhaled spray film containing toluene. In consideration of the clinical signs and radiological imaging suggestive of INH, therapy with desmopressin and corticosteroids was instituted, with gradual improvement of polyuria and resolution of the radiological features of INH.

Conclusion

To our knowledge, we described the first case of INH, manifested with AVP-D, secondary to toluene exposure. In addition, the endocrine effects of toluene inhalation were discussed. Finally, given the scarcity of data available, an overview of all the known toxic substances inducing AVP-D was also provided.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303306378240816104619
2024-09-23
2026-01-27

  • From This Site

    /content/journals/emiddt/10.2174/0118715303306378240816104619
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ChiloiroS. CapoluongoE.D. TartaglioneT. GiampietroA. BianchiA. GiustinaA. PontecorviA. De MarinisL. The changing clinical spectrum of hypophysitis.Trends Endocrinol. Metab.201930959060210.1016/j.tem.2019.06.004 31345630
     [Google Scholar]
  2. Christ-CrainM. BichetD.G. FenskeW.K. GoldmanM.B. RittigS. VerbalisJ.G. VerkmanA.S. Diabetes insipidus.Nat. Rev. Dis. Primers2019515410.1038/s41572‑019‑0103‑2 31395885
     [Google Scholar]
  3. TartaglioneT. ChiloiroS. LainoM.E. GiampietroA. GaudinoS. ZoliA. BianchiA. PontecorviA. ColosimoC. De MarinisL. Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis.Pituitary201821441442410.1007/s11102‑018‑0892‑4 29752700
     [Google Scholar]
  4. GubbiS. Hannah-ShmouniF. KochC.A. VerbalisJ.G. Diagnostic testing for diabetes insipidus.EndotextMDText.comSouth Dartmouth2022 30779536
     [Google Scholar]
  5. TeelucksinghS. SteerC.R. ThompsonC.J. SecklJ.R. DouglasN.J. EdwardsC.R. Hypothalamic syndrome and central sleep apnoea associated with toluene exposure.Q. J. Med.199178286185190 2031080
     [Google Scholar]
  6. AydınB. BotanE. GülensoyB. AkyolS. Hydranencephaly in a newborn due to occupational toluene exposure during pregnancy: a case report.Acute Crit. Care202210.4266/acc.2021.01081 35977900
     [Google Scholar]
  7. DoneganD. HoneggerJ. Hypophysitis.Endocr. Pract.202228990191010.1016/j.eprac.2022.06.009 35779833
     [Google Scholar]
  8. LangloisF. VarlamovE.V. FleseriuM. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease.J. Clin. Endocrinol. Metab.20221071102810.1210/clinem/dgab672 34528683
     [Google Scholar]
  9. KurokawaR. KurokawaM. BabaA. NakayaM. KatoS. BapurajJ. NakataY. OtaY. SrinivasanA. AbeO. MoritaniT. Neuroimaging of hypophysitis: etiologies and imaging mimics.Jpn. J. Radiol.202341991192710.1007/s11604‑023‑01417‑y 37010787
     [Google Scholar]
  10. MizukoshiT. FukuokaH. TakahashiY. Immune checkpoint inhibitor-related hypophysitis.Best Pract. Res. Clin. Endocrinol. Metab.202236310166810.1016/j.beem.2022.101668 35562229
     [Google Scholar]
  11. ChatterjeeS. ChatterjeeS. BhartiyaS. Hypophysitis – A review of fourteen cases.Neurol. India202371111912110.4103/0028‑3886.370481 36861584
     [Google Scholar]
  12. NaranJ. CanA.S. Lymphocytic hypophysitis. StatPearls.Treasure Island, FLStatPearls Publishing2023
     [Google Scholar]
  13. HoneggerJ. GieseS. Nasi-KordhishtiI. DoneganD.M. Pregnancy-related hypophysitis revisited.Eur. J. Endocrinol.20231882R1R1210.1093/ejendo/lvad003 36655394
     [Google Scholar]
  14. RawanduzyC.A. Winkler-SchwartzA. CouldwellW.T. Hypophysitis: Defining histopathologic variants and a review of emerging clinical causative entities.Int. J. Mol. Sci.2023246591710.3390/ijms24065917 36982990
     [Google Scholar]
  15. VakhariaJ.D. MuhammedM. Remba-ShapiroI. MarsigliaM. HadawayN. ChwaliszB.K. NachtigallL.B. A novel approach to hypophysitis: outcomes using non-glucocorticoid immunosuppressive therapy.Eur. J. Endocrinol.2023189330931710.1093/ejendo/lvad115 37602514
     [Google Scholar]
  16. MarkI.T. GlastonburyC.M. Diffuse basisphenoid enhancement: possible differentiating feature for granulomatous hypophysitis.AJNR Am. J. Neuroradiol.20224391341134510.3174/ajnr.A7618 36007945
     [Google Scholar]
  17. VorontsovA.V. BabaevaD.M. VladimirovaV.P. DubovitskayaT.A. GavrilovaA.O. BelayaZ.E. MokryshevаN.G. Clinical and radiological diagnosis of hypophysitis: a review of literature and own data.Probl. Endocrinol.2022682163310.14341/probl12777 35488753
     [Google Scholar]
  18. Esteves-FerreiraS. RosinhaP. Immune checkpoint inhibitor-induced hypophysitis: clinical and biochemical features.J. Cancer Res. Clin. Oncol.2023149107925793210.1007/s00432‑023‑04659‑5 36869230
     [Google Scholar]
  19. BhargavaR. HusseinZ. DorwardN.L. GrieveJ.P. JaunmuktaneZ. MarcusH.J. ProctorI. BaldewegS.E. IgG4-related hypophysitis: a retrospective cohort study.Acta Neurochir. (Wien)202216482095210310.1007/s00701‑022‑05231‑9 35532784
     [Google Scholar]
  20. PatilA. PatilP. WalkeV. Lymphocytic hypophysitis: An underrated disease.J Midlife Health202213325425610.4103/jmh.jmh_32_21 36950203
     [Google Scholar]
  21. ChenP. LiJ. TanH. Progress and challenges of immune checkpoint inhibitor-induced hypophysitis.J. Clin. Med.20231210346810.3390/jcm12103468 37240574
     [Google Scholar]
  22. TripuraneniS. DharmapuriS. GeraS. BoyapatiM. Granulomatous hypophysitis - A case report.Indian J. Otolaryngol. Head Neck Surg.20237521233123710.1007/s12070‑023‑03500‑2 37275024
     [Google Scholar]
  23. NanaM. WilliamsonC. Pituitary and adrenal disorders of pregnancy. EndotextMDText.comSouth Dartmouth2022 25905272
     [Google Scholar]
  24. ElshimyG. RajR. AkturkH.K. SchriberA. SisternaN. AhmadI. JacobA. MichelsA.W. CorreaR. Immune checkpoint inhibitors related endocrine adverse events. EndotextMDText.comSouth Dartmouth2022 35129941
     [Google Scholar]
  25. EvansonJ. FeingoldK.R. AnawaltB. BlackmanM.R. BoyceA. ChrousosG. CorpasE. de HerderW.W. DhatariyaK. DunganK. HoflandJ. KalraS. KaltsasG. KapoorN. KochC. KoppP. KorbonitsM. KovacsC.S. KuohungW. LaferrèreB. LevyM. McGeeE.A. McLachlanR. NewM. PurnellJ. SahayR. ShahA.S. SingerF. SperlingM.A. StratakisC.A. TrenceD.L. WilsonD.P. Radiology of the pituitary. EndotextMDText.comSouth Dartmouth2023 25905384
     [Google Scholar]
  26. ChakrabortyA.M. SahooS.K. ChatterjeeD. DuttaP. KumarR. BhadadaS.K. IgG4-related hypophysitis: A monocentric experience from North India.Surg. Neurol. Int.20221357810.25259/SNI_1013_2022 36600729
     [Google Scholar]
  27. AmirbaiglooA. EsfahanianF. MouodiM. RakhshaniN. ZeinalizadehM. IgG4-related hypophysitis.Endocrine202173227029110.1007/s12020‑021‑02714‑0 33837927
     [Google Scholar]
  28. JoshiM. GunawardenaS. GoenkaA. EyE. KumarG. Post COVID-19 lymphocytic hypophysitis: A rare presentation.Child Neurol Open20222092329048X22110305110.1177/2329048X22110305135615060
     [Google Scholar]
  29. MillerS.R. KumarS. YuileA. MenziesA.M. Hypercalcaemia secondary to hypophysitis and cortisol deficiency: Another immunotherapy-related adverse event.Endocrinol. Diabetes Metab. Case Rep.20232023122037510.1530/EDM‑22‑0375 36648353
     [Google Scholar]
  30. YanY.D. ZhaoY. ZhangC. FuJ. SuY.J. CuiX.L. MaE.L. LiuB.L. GuZ.C. LinH.W. Toxicity spectrum of immunotherapy in advanced lung cancer: A safety analysis from clinical trials and a pharmacovigilance system.EClinicalMedicine20225010153510.1016/j.eclinm.2022.101535 35812997
     [Google Scholar]
  31. HuangH.C. ChenY.T. LinH.H. LiZ.Q. YangJ.M. TzouS.C. Inhibition of IRAK1 is an effective therapy for autoimmune hypophysitis in mice.Int. J. Mol. Sci.202223231495810.3390/ijms232314958 36499283
     [Google Scholar]
  32. ZhengY. ZhuC.Y. LinJ. ChenW.S. WangY.J. FuH.Y. ZhaoQ. Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports.World J. Clin. Cases20221030110491105810.12998/wjcc.v10.i30.11049 36338199
     [Google Scholar]
  33. LinS.H. ZhangA. LiL.Z. ZhaoL.C. WuL.X. FangC.T. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.BMC Endocr. Disord.202222123910.1186/s12902‑022‑01151‑y 36153581
     [Google Scholar]
  34. DaiX.M. JiangL. XuQ.Y. ZhuY. LinQ. ShenY.Y. LiX.Z. A case of juvenile systemic lupus erythematosus with autoimmune hypophysitis.Zhonghua Er Ke Za Zhi2024622177179 38264820
     [Google Scholar]
  35. AngelousiA. AlexandrakiK. TsoliM. KaltsasG. KassiE. Hypophysitis (including IgG4 and immunotherapy).Neuroendocrinology20201109-1082283510.1159/000506903 32126548
     [Google Scholar]
  36. HuangY. LiuY.M. LuZ.H. GanJ.H. ZhaoW.F. HuangX.P. IgG4-related disease with hypophysitis and cholangitis as the main manifestations.Dig. Dis. Sci.20226794317432010.1007/s10620‑022‑07564‑y 35790701
     [Google Scholar]
  37. TuerxunH. ZhaoY. LiY. LiuX. WenS. CaoJ. CuiJ. ZhaoY. Immune checkpoint inhibitors as a threat to reproductive function: A systematic review.Crit. Rev. Oncol. Hematol.202318810406410.1016/j.critrevonc.2023.104064 37379960
     [Google Scholar]
  38. YanR. JinY.B. LiX.R. LuoL. LiuX.M. HeJ. Clinical characteristics of rheumatic disease-associated hypophysitis: A case series and review of literature.Medicine (Baltimore)202210143e3133810.1097/MD.0000000000031338 36316923
     [Google Scholar]
  39. ZhangY. WangS.C. ZhangQ. LiH.Y. LiuS.S. WangX.H. LiuY. Clinical characteristics of programmed cell death-1 inhibitor-associated hypophysitis.Zhonghua Nei Ke Za Zhi2024632192197 38326046
     [Google Scholar]
  40. YangM.G. CaiH.Q. WangS.S. LiuL. WangC.M. Full recovery from chronic headache and hypopituitarism caused by lymphocytic hypophysitis: A case report.World J. Clin. Cases20221031041104910.12998/wjcc.v10.i3.1041 35127918
     [Google Scholar]
  41. FengY. LiC. JiY. LiuY. GanL. YuY. LiuT. Nivolumab combined with ipilimumab treatment induced hypophysitis and immune-mediated liver injury in advanced esophageal squamous cell carcinoma: A case report.Front. Oncol.20221280192410.3389/fonc.2022.801924 35433482
     [Google Scholar]
  42. WangL. ChenX. LiuX. MiaoH. GongF. YangH. DuanL. ZhuH. SunW. Cerebrospinal fluid metabolomic pattern of different pituitary stalk lesions.J. Clin. Endocrinol. Metab.20231093dgad55910.1210/clinem/dgad559 37769631
     [Google Scholar]
  43. LiM. WuC. LiuY. ZhangR. YangQ. ShiZ. SunW. HuX. Autoimmune polyendocrinopathy induced by an antibody (kn046) that simultaneously inhibits pd-l1 and ctla-4: A case report and literature review.Diabetes Metab. Syndr. Obes.2022151253126010.2147/DMSO.S353403 35494533
     [Google Scholar]
  44. LiM.W.T. PoonS.W.Y. CheungC. WongC.K.C. ShingM.M.K. ChowT.T.W. LeeS.L.K. PangG.S.W. KwanE.Y.W. PoonG.W.K. YauH.C. TungJ.Y.L. LiuA.P.Y. Incidence and predictors for oncologic etiologies in chinese children with pituitary stalk thickening.Cancers (Basel)20231515393510.3390/cancers15153935 37568752
     [Google Scholar]
  45. ŞahinS. BaşkurtO. ÇomunoğluN. KadıoğluP. GazioğluN. Germinoma misdiagnosed as lymphocytic hypophysitis.Balkan Med. J.202340429829910.4274/balkanmedj.galenos.2023.2023‑3‑60 37227236
     [Google Scholar]
  46. KaraZ. EşkazanT. ŞahinS. DurcanE. SuluC. DemirA.N. UysalS. ÖzkayaH.M. YılmazE. HatemiA.İ. Bolayırlıİ.M. KadıoğluP. Is there a connection between primary hypophysitis and celiac disease?Exp. Clin. Endocrinol. Diabetes20241321333810.1055/a‑2213‑4375 37977557
     [Google Scholar]
  47. SahinS. YildizG. OguzS.H. CivanO. CicekE. DurcanE. ComunogluN. OzkayaH.M. OzA.B. SoylemezogluF. OguzK.K. DagdelenS. ErbasT. KizilkilicO. KadiogluP. Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging derived texture features.Pituitary202225347447910.1007/s11102‑022‑01213‑3 35334029
     [Google Scholar]
  48. JesselS. WeissS.A. AustinM. MahajanA. EttsK. ZhangL. AizenbudL. PerdigotoA.L. HurwitzM. SznolM. HeroldK.C. KlugerH.M. Immune checkpoint inhibitor-induced hypophysitis and patterns of loss of pituitary function.Front. Oncol.20221283685910.3389/fonc.2022.836859 35350573
     [Google Scholar]
  49. ChenK. YaoY. MaoX. YouH. WangL. DuanL. DengK. ZhangW. LianX. ZhuH. Sellar germinoma mimicking IgG4-related hypophysitis: a case report.BMC Endocr. Disord.20222212310.1186/s12902‑021‑00930‑3 35033046
     [Google Scholar]
  50. YangX. YeX. HanX. MengM. ZhangT. WangJ. HuangG. NiY. LiW. DaiJ. Hypophysitis: A rare but noteworthy immune-related adverse event secondary to camrelizumab therapy.J. Cancer Res. Ther.20221851440144310.4103/jcrt.jcrt_831_21 36204895
     [Google Scholar]
  51. YuY. ZhouG. DuJ. ZhuH. GuanH. BiY. ZhangD. Hypophysitis after COVID-19 vaccination in a patient with Rathke’s cleft cyst: A case report.Hum. Vaccin. Immunother.2024201229745510.1080/21645515.2023.2297455 38174857
     [Google Scholar]
  52. LvK. CaoX. GengD.Y. ZhangJ. Imaging findings of immunoglobin G4-related hypophysitis: A case report.World J. Clin. Cases202210269440944610.12998/wjcc.v10.i26.9440 36159431
     [Google Scholar]
  53. ZhangN. QuX. ZhangX. SunX. KangL. Immunotherapy-induced hypophysitis following ici treatment with tislelizumab in an elderly patient with bladder cancer and prostate cancer: A case report.Cureus20231512e5101510.7759/cureus.51015 38146338
     [Google Scholar]
  54. SinghG. JialalI. Polyglandular autoimmune syndrome Type II. StatPearls.Treasure IslandStatPearls Publishing2023 30252248
     [Google Scholar]
  55. YuS. KarsyM. PrashantG.N. BartonB. RosenM.R. ParkesW. EvansJ.J. Minimally invasive endoscopic approaches to pediatric skull base pathologies.Int. J. Pediatr. Otorhinolaryngol.202216211133210.1016/j.ijporl.2022.111332 36206699
     [Google Scholar]
  56. SaishuY. YoshidaT. SeinoY. NomuraT. Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report.J. Med. Case Reports20221616110.1186/s13256‑022‑03286‑x 35152911
     [Google Scholar]
  57. YuY. XuL. WangY. LiW. WangY. Glucocorticoid impact therapy for recurrent IgG4-related disease with diabetes insipidus as the main manifestation: A case report and literature review.Medicine202310246e3612910.1097/MD.0000000000036129 37986296
     [Google Scholar]
  58. PoirierA. DoddsL. DummerT. RainhamD. MaguireB. JohnsonM. Maternal exposure to air pollution and adverse birth outcomes in halifax, nova scotia.J. Occup. Environ. Med.201557121291129810.1097/JOM.0000000000000604 26641824
     [Google Scholar]
  59. LudererU. MorganM.S. BrodkinC.A. KalmanD.A. FaustmanE.M. Reproductive endocrine effects of acute exposure to toluene in men and women.Occup. Environ. Med.1999561065766610.1136/oem.56.10.657 10658543
     [Google Scholar]
  60. TapO. SolmazS. PolatS. MeteU.O. OzbilgïnM.K. KayaM. The effect of toluene on the rat ovary: an ultrastructural study.J. Submicrosc. Cytol. Pathol.1996284553558 8933738
     [Google Scholar]
  61. StepanovM.G. AltukhovV.V. ProĭminaF.I. SavchenkoO.N. DanilovaO.A. [Physiologic mechanisms of the reaction of the reproductive system in female rats to chronic exposure to low doses of toluene].Fiziol. Zh. SSSR Im. I M Sechenova199076810961102 2177007
     [Google Scholar]
  62. NTP Toxicology and carcinogenesis studies of vinyl toluene (Mixed Isomers) (65%-71% meta-isomer and 32-35% para-isomer) (CAS No. 25013-15-4) in F344/N Rats and B6C3F1 mice (Inhalation Studies).Natl. Toxicol. Program Tech. Rep. Ser.19903751191 12692646
     [Google Scholar]
  63. PoonR. ChuI. BjarnasonS. PotvinM. VincentR. MillerR.B. ValliV.E. Inhalation toxicity study of methanol, toluene, and methanol/toluene mixtures in rats: effects of 28-day exposure.Toxicol. Ind. Health199410323124510.1177/074823379401000310 7855870
     [Google Scholar]
  64. OnoA. SekitaK. OhnoK. HiroseA. OgawaY. SaitoM. NaitoK. KanekoT. FuruyaT. MatsumotoK. TanakaS. KurokawaY. Reproductive and developmental toxicity studies of toluene. I. Teratogenicity study of inhalation exposure in pregnant rats.J. Toxicol. Sci.199520210913410.2131/jts.20.109 7473890
     [Google Scholar]
  65. OnoA. SekitaK. OgawaY. HiroseA. SuzukiS. SaitoM. NaitoK. KanekoT. FuruyaT. KawashimaK. YasuharaK. MatsumotoK. TanakaS. InoueT. KurokawaY. Reproductive and developmental toxicity studies of toluene. II. Effects of inhalation exposure on fertility in rats.J. Environ. Pathol. Toxicol. Oncol.1996151920 9037260
     [Google Scholar]
  66. OnoA. KawashimaK. SekitaK. HiroseA. OgawaY. SaitoM. NaitoK. YasuharaK. KanekoT. FuruyaT. InoueT. KurokawaY. Toluene inhalation induced epididymal sperm dysfunction in rats.Toxicology1999139319320510.1016/S0300‑483X(99)00120‑1 10647920
     [Google Scholar]
  67. KanterM. Thymoquinone reestablishes spermatogenesis after testicular injury caused by chronic toluene exposure in rats.Toxicol. Ind. Health201127215516610.1177/0748233710382541 20837561
     [Google Scholar]
  68. YilmazB. KutluS. CanpolatS. SandalS. AyarA. MogulkocR. KelestimurH. Effects of paint thinner exposure on serum LH, FSH and testosterone levels and hypothalamic catecholamine contents in the male rat.Biol. Pharm. Bull.200124216316610.1248/bpb.24.163 11217085
     [Google Scholar]
  69. YilmazB. CanpolatS. SandalS. AkpolatN. KutluS. IlhanN. KelestimurH. Paint thinner exposure inhibits testosterone synthesis and secretion in a reversible manner in the rat.Reprod. Toxicol.200622479179610.1016/j.reprotox.2006.08.002 16978833
     [Google Scholar]
  70. TsukaharaS. NakajimaD. KurodaY. HojoR. KageyamaS. FujimakiH. Effects of maternal toluene exposure on testosterone levels in fetal rats.Toxicol. Lett.20091852798410.1016/j.toxlet.2008.12.001 19110042
     [Google Scholar]
  71. BurmistrovS.O. ArutyunyanA.V. StepanovM.G. OparinaT.I. ProkopenkoV.M. Effect of chronic inhalation of toluene and dioxane on activity of free radical processes in rat ovaries and brain.Bull. Exp. Biol. Med.2001132383283610.1023/A:1013106315140 11740571
     [Google Scholar]
  72. von EulerG. OgrenS.O. EnerothP. FuxeK. GustafssonJ.A. Persistent effects of 80 ppm toluene on dopamine-regulated locomotor activity and prolactin secretion in the male rat.Neurotoxicology1994153621624 7854597
     [Google Scholar]
  73. HongJ.J. LinJ.L. WuM.S. HuangC.C. VerberckmoesR. A chronic glue sniffer with hyperchloraemia metabolic acidosis, rhabdomyolysis, irreversible quadriplegia, central pontine myelinolysis, and hypothyroidism.Nephrol. Dial. Transplant.19961191848184910.1093/oxfordjournals.ndt.a027683 8918637
     [Google Scholar]
  74. KamijoY. SomaK. HasegawaI. OhwadaT. Fatal bilateral adrenal hemorrhage following acute toluene poisoning: a case report.J. Toxicol. Clin. Toxicol.199836436536810.3109/15563659809028034 9711204
     [Google Scholar]
  75. GotohdaT. TokunagaI. KuboS. Toluene inhalation-induced adrenocortical hypertrophy and endocrinological changes in rat.Life Sci.200576171929193710.1016/j.lfs.2004.08.035 15707876
     [Google Scholar]
  76. GotohdaT. NishimuraA. MoritaK. Immunohistochemical studies on early stage of hepatic damage induced by subacute inhalation of toluene vapor in rats.J. Appl. Toxicol.200929650550910.1002/jat.1435 19391120
     [Google Scholar]
  77. CrossinR. AndrewsZ.B. SimsN.A. PangT. MathaiM. GooiJ.H. StefanidisA. OldfieldB.J. LawrenceA.J. DuncanJ.R. Adolescent Inhalant abuse results in adrenal dysfunction and a hypermetabolic phenotype with persistent growth impairments.Neuroendocrinology2018107434035410.1159/000493686 30208370
     [Google Scholar]
  78. CrossinR. QamaA. AndrewsZ.B. LawrenceA.J. DuncanJ.R. The effect of adolescent inhalant abuse on energy balance and growth.Pharmacol. Res. Perspect.201974e0049810.1002/prp2.498 31384470
     [Google Scholar]
  79. LittleA.R.Jr GongZ. SinghU. El-FawalH. EvansH.L. Decreases in brain glial fibrillary acidic protein (GFAP) are associated with increased serum corticosterone following inhalation exposure to toluene.Neurotoxicology1998194-5739747 9745935
     [Google Scholar]
  80. Soberanes-ChávezP. de GortariP. García-LunaC. CruzS.L. Repeated toluene and cyclohexane inhalation produces differential effects on HPA and HPT axes in adolescent male rats.Neurotoxicology20239924425310.1016/j.neuro.2023.11.003 37944760
     [Google Scholar]
  81. TähtiH. AaranR.K. VapaataloH. An inhalation method for testing the toxicity of volatile compounds in small laboratory animals. A study on short-term and long-term toluene inhalation in rats.Methods Find. Exp. Clin. Pharmacol.1983510667671 6672485
     [Google Scholar]
  82. IshigamiA. TokunagaI. KuboS. GotohdaT. Immunohistochemical study of rat spermatogenesis after toluene-inhalation.Leg. Med. (Tokyo)200571424610.1016/j.legalmed.2004.07.005 15556014
     [Google Scholar]
  83. DalgaardM. HossainiA. HougaardK.S. HassU. LadefogedO. Developmental toxicity of toluene in male rats: effects on semen quality, testis morphology, and apoptotic neurodegeneration.Arch. Toxicol.200175210310910.1007/s002040000209 11354905
     [Google Scholar]
  84. KyrklundT. KjellstrandP. HaglidK. Brain lipid changes in rats exposed to xylene and toluene.Toxicology198745212313310.1016/0300‑483X(87)90098‑9 3603578
     [Google Scholar]
  85. YamadaK. Influence of lacquer thinner and some organic solvents on reproductive and accessory reproductive organs in the male rat.Biol. Pharm. Bull.199316442542710.1248/bpb.16.425 8358395
     [Google Scholar]
  86. DickA.L.W. SimpsonA. QamaA. AndrewsZ. LawrenceA.J. DuncanJ.R. Chronic intermittent toluene inhalation in adolescent rats results in metabolic dysfunction with altered glucose homeostasis.Br. J. Pharmacol.2015172215174518710.1111/bph.13284 26282596
     [Google Scholar]
  87. BrucknerJ. PetersonR.G. Evaluation of toluene and acetone inhalant abuse II. Model development and toxicology*1.Toxicol. Appl. Pharmacol.198161330231210.1016/0041‑008X(81)90351‑3 7330874
     [Google Scholar]
  88. LangloisF. VarlamovEV. FleseriuM. Hypophysitis, the growing spectrum of a rare pituitary disease.J Clin Endocrinol Metab2022107110.1210/clinem/dgab67234528683
     [Google Scholar]
  89. GubbiS. Hannah-ShmouniF. StratakisC.A. KochC.A. Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions.Rev. Endocr. Metab. Disord.201819433534710.1007/s11154‑018‑9480‑1 30547288
     [Google Scholar]
  90. ChiloiroS. TartaglioneT. AngeliniF. BianchiA. ArenaV. GiampietroA. MormandoM. SciandraM. LainoM.E. De MarinisL. An overview of diagnosis of primary autoimmune hypophysitis in a prospective single-center experience.Neuroendocrinology2017104328029010.1159/000446544 27165294
     [Google Scholar]
  91. GrünfeldJ.P. RossierB.C. Lithium nephrotoxicity revisited.Nat. Rev. Nephrol.20095527027610.1038/nrneph.2009.43 19384328
     [Google Scholar]
  92. ImamS.K. HasanA. ShahidS.K. Lithium-induced nephrogenic diabetes insipidus.J. Pak. Med. Assoc.2005553125127 15852752
     [Google Scholar]
  93. IzzedineH. Launay-VacherV. DerayG. Antiviral drug-induced nephrotoxicity.Am. J. Kidney Dis.200545580481710.1053/j.ajkd.2005.02.010 15861345
     [Google Scholar]
  94. Frasca’G.M. BalestraE. TavioM. MorroniM. ManariniG. BriganteF. [Renal toxicity of antiviral drugs].G. Ital. Nefrol.201229Suppl. 56S109S114[Renal toxicity of antiviral drugs]. 23059948
     [Google Scholar]
  95. KarrasA. LafaurieM. FurcoA. BourgaritA. DrozD. SereniD. LegendreC. MartinezF. MolinaJ.M. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.Clin. Infect. Dis.20033681070107310.1086/368314 12684922
     [Google Scholar]
  96. IzzedineH. [Pemetrexed nephrotoxicity].Bull. Cancer2015102219019710.1016/j.bulcan.2014.12.012 25641712
     [Google Scholar]
  97. FungE. AnandS. BhallaV. Pemetrexed-Induced Nephrogenic Diabetes Insipidus.Am. J. Kidney Dis.201668462863210.1053/j.ajkd.2016.04.016 27241854
     [Google Scholar]
  98. StavroulopoulosA. NakopoulouL. XydakisA.M. ArestiV. NikolakopoulouA. KlouvasG. Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed.Ren. Fail.20103281000100410.3109/0886022X.2010.501930 20722569
     [Google Scholar]
  99. VootukuruV. LiewY.P. NallyJ.V.Jr Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer.Med. Oncol.200623341942210.1385/MO:23:3:419 17018900
     [Google Scholar]
  100. DermanB. JainM. McAninchE. GashtiC. Bendamustine-induced nephrogenic diabetes insipidus.Clin. Nephrol.2017871475010.5414/CN108908 27719738
     [Google Scholar]
  101. PumaN. RuggieroA. ScalzoneM. CocciaP. TriaricoS. TrombatoreG. MastrangeloS. RiccardiR. Platinum compounds and sodium metabolism in children with diencephalic glioma.J. Neurooncol.2013115111311710.1007/s11060‑013‑1203‑6 23839227
     [Google Scholar]
  102. TsukamotoS. KurematsuY. HonokiK. KidoA. SomekawaS. KayaD. SadamitsuT. FukuiH. TanakaY. Severe toxicity of chemotherapy against advanced soft tissue sarcoma in Werner’s syndrome: Ifosfamide-induced encephalopathy with central diabetes insipidus.J. Orthop. Sci.201621340340610.1016/j.jos.2015.06.012 26740452
     [Google Scholar]
  103. CabibelR. GerardL. MaiterD. CollinV. HantsonP. Complete nephrogenic diabetes insipidus after prolonged sevoflurane sedation: A case report of 3 cases.A A Pract.201912515515910.1213/XAA.0000000000000871 30130280
     [Google Scholar]
  104. SilversidesJ.A. ScottK.C. Diabetes insipidus following overdose of baclofen and quetiapine.Anaesth. Intensive Care200937231932010.1177/0310057X0903700218 19400501
     [Google Scholar]
  105. Suvr. Med. (Sofiia)19611278386A case of diabetes insipidus following the application of largactil.
     [Google Scholar]
  106. Di DalmaziG. IppolitoS. LupiI. CaturegliP. Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment.Expert Rev. Endocrinol. Metab.201914638139810.1080/17446651.2019.1701434 31842671
     [Google Scholar]
  107. TanM.H. IyengarR. Mizokami-StoutK. YentzS. MacEachernM.P. ShenL.Y. RedmanB. GianchandaniR. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.Clin. Diabetes Endocrinol.201951110.1186/s40842‑018‑0073‑4 30693099
     [Google Scholar]
  108. ChiloiroS. BianchiA. GiampietroA. MilardiD. De MarinisL. PontecorviA. The changing clinical spectrum of endocrine adverse events in cancer immunotherapy.Trends Endocrinol. Metab.20223328710410.1016/j.tem.2021.10.009 34895977
     [Google Scholar]
  109. KobaldS.O. WascherE. BlaszkewiczM. GolkaK. van ThrielC. Neurobehavioral and neurophysiological effects after acute exposure to a single peak of 200 ppm toluene in healthy volunteers.Neurotoxicology201548505910.1016/j.neuro.2015.03.005 25770824
     [Google Scholar]
  110. BjornaesS. NaalsundL.U. Biochemical changes in different brain areas after toluene inhalation.Toxicology1988492-336737410.1016/0300‑483X(88)90020‑0 2836974
     [Google Scholar]
  111. LakeD. CorrêaSAL. MüllerJ. NMDA receptor-dependent signalling pathways regulate arginine vasopressin expression in the paraventricular nucleus of the rat.Brain Res20191172214635710.1016/j.brainres.2019.14635731369731
     [Google Scholar]
  112. MaioneS. VitaglianoS. BerrinoL. LampaE. RossiF. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.Neuropharmacology199231440340710.1016/0028‑3908(92)90074‑Y 1355901
     [Google Scholar]
  113. KimY.B. KimY.S. KimW.B. ShenF.Y. LeeS.W. ChungH.J. KimJ.S. HanH.C. ColwellC.S. KimY.I. GABAergic excitation of vasopressin neurons: possible mechanism underlying sodium-dependent hypertension.Circ. Res.2013113121296130710.1161/CIRCRESAHA.113.301814 24103391
     [Google Scholar]
  114. DemırM. CicekM. EserN. YoldaşA. SısmanT. Effects of acute toluene toxicity on different regions of rabbit brain.Anal. Cell. Pathol. (Amst.)201720171610.1155/2017/2805370 28458992
     [Google Scholar]
  115. StengårdK. ThamR. O’ConnorW.T. HöglundG. UngerstedtU. Acute toluene exposure increases extracellular GABA in the cerebellum of rat: a microdialysis study.Pharmacol. Toxicol.199373631531810.1111/j.1600‑0773.1993.tb01358.x 8153054
     [Google Scholar]
  116. Paez-MartinezN. Aldrete-AudiffredJ. Gallardo-TenorioA. Castro-GarciaM. Estrada-CamarenaE. Lopez-RubalcavaC. Participation of GABAA, GABA(B) receptors and neurosteroids in toluene-induced hypothermia: Evidence of concentration-dependent differences in the mechanism of action.Eur. J. Pharmacol.20136981-317818510.1016/j.ejphar.2012.10.004.x 23085024
     [Google Scholar]
  117. WilliamsJ. StaffordD. SteketeeJ. Effects of repeated inhalation of toluene on ionotropic GABA and glutamate receptor subunit levels in rat brain.Neurochem. Int.200546111010.1016/j.neuint.2004.07.006 15567510
     [Google Scholar]
/content/journals/emiddt/10.2174/0118715303306378240816104619
Loading
A Toluene-induced Infundibulo-neuro-hypophysitis: Presentation of a New Cause of Hypophysitis Secondary to Toxic Exposure and Review on Toluene Inhalation Endocrine Effects
Endocr Metab Immune Disord Drug Targets 25, 1122 (2025); https://doi.org/10.2174/0118715303306378240816104619
/content/journals/emiddt/10.2174/0118715303306378240816104619
/content/journals/emiddt/10.2174/0118715303306378240816104619
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): arginine vasopressin deficiency; diabetes insipidus; endocrine effects; Neuro-hypophysitis; secondary hypophysitis; toluene exposure; toluene inhalation; toxic exposure; toxic-induced

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test